Us Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028
Submitted by Sonika Shukla | February 22, 2022, 11:15:58 | Business
In last few years, therapeutic antibodies have gained maximum share in the US cancer therapeutics market. Their ability to specifically target the antigens on cancer has enabled the development of several targeted therapies. Further, advancement in the field of biotechnology has also led to development of new generation therapeutic agents.
